Background: Myopericytomas with intravascular growth have been reported and have been occasionally documented as intraarterial. In a retrospective study, we assessed intraarterial growth in myopericytomas, co-existence with arterial intimal thickening (IT) and the relationship between the two.
Methods: This retrospective study was undertaken using 11 myopericytomas evaluated in serial microscopical sections. The results in light microscopy, electron microscopy and immunohistochemistry [including α-smooth muscle actin (SMA), desmin and h-caldesmon] were evaluated.
Results: In four myopericytomas, we found intraarterial growth, with large areas of disrupted arterial wall and attachment of veins and venules, exhibiting angiogenic phenomena. Arterial IT was present and partially incorporated within the tumor (simulating medium-sized vessels). The neointimal (myointimal) cells shared morphological and immunohistochemical phenotype with the myopericytoma myoid cells, including α-SMA positivity and desmin negativity. Four of the remaining myopericytomas showed structures similar to arterial IT within the tumor.
Conclusions: The findings shown here, including the association between myopericytomas and arterial IT, the incorporation of the latter into the tumor and the similar phenotype of their respective myoid and myointimal cells, support a close relationship between these processes. Histogenically, the pericytes of the penetrating neovasculature originating from the attached venules and veins may contribute to both lesions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1600-0560.2011.01778.x | DOI Listing |
Curr Opin Organ Transplant
December 2024
Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
Purpose Of Review: Allograft vasculopathy in vascularized composite allografts (VCA) remains understudied. This review explores the vascular changes in VCA, focused on recent literature.
Recent Findings: Allograft vasculopathy in VCA generally includes progressive concentric myointimal thickening and luminal narrowing of arterial vessels through endothelial deterioration and proliferation of smooth muscle cells.
Pathology
February 2025
Department of Gastroenterology, Zhongnan Hospital of Wuhan University, China. Electronic address:
Front Cardiovasc Med
March 2024
Cardiology and Cardiac Surgery, McGill University Health Center, Montreal, QC, Canada.
Introduction: The progression of coronary atherosclerosis is an active and regulated process. The Wnt signaling pathway is thought to play an active role in the pathogenesis of several cardiovascular diseases; however, a better understanding of this system in atherosclerosis is yet to be unraveled.
Methods: In this study, real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting were used to quantify the expression of Wnt3a, Wnt5a, and Wnt5b in the human coronary plaque, and immunohistochemistry was used to identify sites of local expression.
Ultrastruct Pathol
February 2023
Amsterdam UMC Location University of Amsterdam, Department of Internal Medicine, Amsterdam, the Netherlands.
The association between uterine smooth muscle fibroids and systemic arterial hypertension is poorly understood. Therefore, we explored possible concomitant myocyte pathology of systemic resistance-sized arterioles (200 to 400 μm), isolated from omental samples donated by 19 women (mean age 42 y; SE 1) undergoing fibroid surgery. Vessels of 17 women (8 hypertensives) were available for transmission electron microscopy.
View Article and Find Full Text PDFInt J Surg Pathol
August 2023
Department of Pathology, Montefiore Medical Center, Bronx, NY, USA.
Penile myointimoma is a rare, benign tumor occurring within the corpus spongiosum vasculature of the glans penis. Thus far, there have been twenty-three reported tumors in the literature. We present four additional tumors of this unique myointimal proliferation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!